Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 2

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 2
---

     312,000  
     385,000 
  
    Total revenues 
     71,638,000  
     49,257,000  
     183,211,000  
     132,783,000 
  
    Cost of sales 
     (17,712,000) 
     (12,018000) 
     (49,466,000) 
     (35,110,000)
  
    Gross profit 
     53,926,000  
     37,239,000  
     133,745,000  
     97,673,000 
  
    Operating expenses: 

    Selling, general and administrative 
     35,856,000  
     33,645,000  
     109,604,000  
     94,275,000 
  
    Research and development 
     3,323,000  
     2,273,000  
     9,217,000  
     7,475,000 
  
    Total operating expenses 
     39,179,000  
     35,918,000  
     118,821,000  
     101,750,000 
  
    Income (loss) from operations 
     14,747,000  
     1,321,000  
     14,924,000  
     (4,077,000)
  
    Other (expense) income: 

    Interest expense, net 
     (6,038,000) 
     (5,525,000) 
     (18,994,000) 
     (16,411,000)
  
    Investment loss from Eton Pharmaceuticals 
     -  
     -  
     -  
     (3,171,000)
  
    Loss on extinguishment of debt 
     (7,750,000) 
        
     (7,750,000) 

    Other income, net 
     61,000  
     4,000  
     55,000  
     76,000 
  
    Total other expense, net 
     (13,727,000) 
     (5,521,000) 
     (26,689,000) 
     (19,506